Novo Thiamine Hydrochloride Injection IP

About Us

One of the track record in Indian Pharmaceutical Industry of brand building, strategic marketing and ethical promotions of Vaccines, Oncology, Immunoglobulins, Blood Products, Gonadotropins, Critical care drugs. Long standing relationships with a tremendous good will amongst Medical fraternity all over India. One of the Biggest network of distributors across India. In house Medical and Technical team for Product innovation, manufacturing, clinical trails, registration and scientific prominent life saving drugs. History has a special mention of our founder, Mr. R. C. Bhagat, for over six decades now, since its inception in 1946, in life saving drugs, vaccines and critical care products. Mr. Vipul R. Bhagat President & Founder I strongly believe in Quality. Quality isn’t something that can be argued into an article or promised into it. It must be a culture and one of the key ingredients of the manufacturing processes. Even the finest sales talk cannot be its substitute.A Mumbai University Graduate, with over 40 years of varied experience in the pharmaceutical industry. His flair for innovation and aggressive marketing has resulted in several cash cow brands. With his dynamic leadership and people skills, he is instrumental in developing the business to great heights. This dynamic young CEO started her career as a trainee in 1992 at the age of 18, and through her hard work and dedication earned the highest position in the organization by 2004 and won the award in 2007 As a great lover of humanity, Shri R. C. Bhagat cherished the ideal that Medicines were for the people and not for profits. He was honored with the Lifetime Award in 2016. He was always leading from the front, helping as Set up of 5 modern manufacturing sites compliant with USFDA, MHRA at Uttarakhand in India under the guidance of NOVO Management. NOVO Management bagged prestigious ‘ASSOCHAM AWARDS’ in the category of India’s Fastest Growing Pharmaceutical Company in the year 2009. Management witnessed dramatic growth and through their aggressive positioning and strategy the Organization won many laurels and awards. Indian Drug Manufacturer's Association confers NOVO Management wins the "Quality Excellence Award 2009" for formulations unit - turnover above 100 crores. Excellence in Economic Development Award function, at the 23rd Indian Achievers Summit on 22nd April 2010 at India Habitat Centre, New Delhi. Woman Entrepreneur Award 2010 was given to Ms. Anju Gupta Kaudanya – Managing Director. The awards are given to honor organizations and individuals that have brought positive change in urban, suburban and rural. NOVO was recognized as One of the Fastest Growing Pharma Company in 2016 for its Varicella Vaccine, Nexipox which was launched in 2015. Nexipox was Ranked No. 2 All India within 1 year of its launch. More than 0.25 Million babies were vaccinated with Nexipox and NOVO is recognized as the ‘’Emerging Company of the Year 2016’’ NEXIPOX was recognised by the ACVIP committee of IAP (India's largest Pediatric Association) in the year 2018 on the basis of the proven fact that NEXIPOX is superior than other varicella vaccine in terms of higher and better The Next Generation Pediatric Oral Range solves the most common unsolved problem faced by Parents, Children & Doctors. Through years of R&D, Novo has made major breakthrough by Introducing, for the First Time in India, Unique Self Dispensing Technology Pack with Most Palatable Taste & Enhanced Stability. Starting a career at Novo Medi Sciences Pvt Ltd is more than getting a job. It is an opportunity to improve the lives of millions of people.We’re a dynamic company in an even more dynamic industry, + Read More

Nature of Business

Trader - Wholesaler/Distributor

Legal Status of Firm

Limited Company

Annual Turnover

25 - 100 Cr

GST Registration Date

Jul'17

Total Number of Employees

101 to 500 People

Import Export Code (IEC)

031*****52

GST Number

27**********1ZJ

IndiaMART Certification

Trust Seal Verified

Our Products

Deals in HSN Code

HSN CodeHSN Description

30022029Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products vaccines for human medicine mixed vaccines : other

Developed and Managed by IndiaMART InterMESH Limited

(Mobile Site)

Novo Medi Sciences Private Limited